// App-Quantinova.ai

: Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With Comorbid Allergic Rhinitis or Asthma

Researchers

Presenter

  • Jonathan Spergel

Principal Investigators

  • Michael Blaiss

  • Peter Lio

  • Aharon Kessel

  • Liza Takiya

  • John Werth

  • Michael O'Connell

  • Chuanbo Zang

  • Michael Cork

Medical Centers

  • The Childrens Hospital of Philadelphia, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

  • Medical College of Georgia Cancer Center, Augusta University, Augusta, GA.

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • Banai-Zion Medical Center, Haifa, Israel

  • Pfizer Inc, Collegeville, PA

  • Sheffield Dermatology Research, University of Sheffield, Sheffield, UK

Locations

  • United States

  • Israel

  • United Kingdom

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Dermatology

  • Infectious Diseases (ID)

  • Autoimmune (AI)

Disease

  • Allergic rhinitis

  • Atopic Dermatitis

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Crisaborole

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved